PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability

This protocol presents the steps for developing a generic core PRO set for children and adults with GID. The next step involves selecting suitable patient reported outcome measures (PROMs) to adequately measure these PROs: the generic core PROM set. This generic core PROM set needs validation in the GID population, and eventually implementation in care and research, facilitating the aggregation and analysis of PRO data and guaranteeing continuous integration of the patient perspective in both care and research.

Authors

Institutions

Publication Details

Journal
Orphanet Journal of Rare Diseases
Published
2024-09-27
DOI
https://doi.org/10.1186/s13023-024-03264-0
Citations
6
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
3.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability

Maud M. van Muilekom, Lotte Haverman, Agnies M. van Eeghen, Nadia Y. van Silfhout et al.
6 citations
Orphanet Journal of Rare Diseases
Genetics and Neurodevelopmental Disorders
3.30
article

PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability

Maud M. van Muilekom, Lotte Haverman, Agnies M. van Eeghen, Nadia Y. van Silfhout, Clara D. van Karnebeek
article en
6 citations

Abstract

This protocol presents the steps for developing a generic core PRO set for children and adults with GID. The next step involves selecting suitable patient reported outcome measures (PROMs) to adequately measure these PROs: the generic core PROM set. This generic core PROM set needs validation in the GID population, and eventually implementation in care and research, facilitating the aggregation and analysis of PRO data and guaranteeing continuous integration of the patient perspective in both care and research.

Orphanet Journal of Rare DiseasesVol. 19(1)
Emma Kinderziekenhuis (NL), Amsterdam Institute for Global Health and Development (NL), Public Health Service of Amsterdam (NL), Child Development Center (QA), Amsterdam University Medical Centers (NL), 's Heeren Loo (NL), Amsterdam University of Applied Sciences (NL), University of Amsterdam (NL)
's Heeren Loo
Quality Education
Openalex Percentile: Top 8%
Genetics and Neurodevelopmental Disorders
3.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability — Maud M. van Muilekom, Lotte Haverman, et al. · Orphanet Journal of Rare Diseases (2024) | TGRS Research Map | TGRS